| dc.contributor.author | Groppa, Liliana | |
| dc.contributor.author | Russu, Eugen | |
| dc.contributor.author | Chişlari, Lia | |
| dc.contributor.author | Rotari, Larisa | |
| dc.contributor.author | Agachi, Svetlana | |
| dc.date.accessioned | 2019-06-10T14:51:59Z | |
| dc.date.available | 2019-06-10T14:51:59Z | |
| dc.date.issued | 2017 | |
| dc.identifier.citation | GROPPA, Liliana; RUSSU, Eugen; CHIŞLARI, Lia; ROTARI, Larisa; AGACHI, Svetlana. Importanţa manifestărilor procesului inflamator în diagnosticul timpurii la pacienţii cu spondiloartrită anchilozantă. In: Sănătate Publică, Economie şi Management în Medicină. 2017, nr. 3(73), pp. 135-139. ISSN 1729-8687. | en_US |
| dc.identifier.issn | 1729-8687 | |
| dc.identifier.uri | https://repository.usmf.md/handle/20.500.12710/1434 | |
| dc.identifier.uri | http://revistaspemm.md/wp-content/uploads/2019/04/cm3_73_2017cg-2.pdf | |
| dc.description | Departamentul Medicină Internă, IP USMF Nicolae Testemiţanu | en_US |
| dc.description.abstract | The disease activity threshold necessary to start DMARD by combined or monotherapy was established arbitrary, for patient with axial spondyloarthritis, at BASDAI ≥ 4. At the moment, the correlation between the activity of the disease and pain, inflammation and the impairment of spinal motor function. The objection of the study was to systematically compare the clinical, laboratory and radiological data of patients with SpAax with the BASDAI index. 100 patients that haven’t been previously treated with biological drugs were included in the study. | en_US |
| dc.language.iso | ro | en_US |
| dc.publisher | Asociația Obștească "Economie, Management și Psihologie în Medicină" din Republica Moldova | en_US |
| dc.relation.ispartof | Sănătate Publică, Economie şi Management în Medicină: Al III-lea Congres al medicilor interniști din Republica Moldova cu participare internațională 24–25 octombrie 2017 Chișinău, Republica Moldova | |
| dc.subject.ddc | CZU 616.721-002.77-07 | |
| dc.subject.mesh | Spondylitis, Ankylosing--diagnosis | en_US |
| dc.subject.mesh | Spondylitis, Ankylosing--complications | en_US |
| dc.subject.mesh | Inflammation--diagnosis | en_US |
| dc.subject.mesh | Motor Activity--physiology | en_US |
| dc.subject.mesh | Musculoskeletal System--physiopathology | en_US |
| dc.subject.mesh | Antirheumatic Agents--therapeutic use | en_US |
| dc.title | Importanţa manifestărilor procesului inflamator în diagnosticul timpuriu la pacienţii cu spondiloartrită anchilozantă | en_US |
| dc.title.alternative | Importance of inflammatory process manifestations in early diagnosis in patients with ankylosing spondylitis | en_US |
| dc.type | Other | en_US |